These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators. Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS. Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527 [Abstract] [Full Text] [Related]
25. [Current diagnostic methods for papillary carcinoma of the thyroid]. Solymosi T. Orv Hetil; 2000 May 07; 141(19):1048-50. PubMed ID: 10846427 [No Abstract] [Full Text] [Related]
27. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule. Carpi A, Nicolini A, Gross MD, Fig LM, Shapiro B, Fanti S, Rampin L, Polico C, Rubello D. Biomed Pharmacother; 2005 Oct 07; 59(9):517-20. PubMed ID: 16202555 [Abstract] [Full Text] [Related]
28. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland]. Iushkov PV, Antonova SS, Bartolazzi A. Arkh Patol; 2004 Oct 07; 66(6):39-42. PubMed ID: 15648166 [Abstract] [Full Text] [Related]
29. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Carcangiu ML, Zampi G, Rosai J. Pathol Annu; 1985 Oct 07; 20 Pt 1():1-44. PubMed ID: 3887295 [No Abstract] [Full Text] [Related]
30. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations]. Hayashi N, Kitaoka M. Nihon Rinsho; 2007 Nov 07; 65(11):2003-7. PubMed ID: 18018562 [Abstract] [Full Text] [Related]
31. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S. Arch Surg; 2004 Jan 07; 139(1):83-8. PubMed ID: 14718282 [Abstract] [Full Text] [Related]
32. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R. Pol J Pathol; 2003 Jan 07; 54(2):111-5. PubMed ID: 14575419 [Abstract] [Full Text] [Related]
33. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size. Cvejic DS, Savin SB, Petrovic IM, Paunovic IR, Tatic SB, Havelka MJ. Head Neck; 2005 Dec 07; 27(12):1049-55. PubMed ID: 16155918 [Abstract] [Full Text] [Related]
34. [Current anatomopathological aspects of differentiated thyroid cancers of follicular (vesicular) origin: value and necessity of a common language]. Franc B. Ann Chir; 1995 Dec 07; 49(10):909-21. PubMed ID: 8787318 [Abstract] [Full Text] [Related]
35. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E. Hum Pathol; 2000 Apr 07; 31(4):428-33. PubMed ID: 10821488 [Abstract] [Full Text] [Related]
36. [Critical reflections on differentiated carcinoma of the thyroid: difficulties, doubts and differential-diagnosis problems]. Autelitano F, Spagnoli LG, Santeusanio G, Villaschi S, Autelitano M. Ann Ital Chir; 1989 Apr 07; 60(4):267-80; discussion 280-1. PubMed ID: 2699711 [Abstract] [Full Text] [Related]
37. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Diagn Cytopathol; 2006 May 07; 34(5):330-4. PubMed ID: 16604553 [Abstract] [Full Text] [Related]
38. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M. Endocr Relat Cancer; 2005 Jun 07; 12(2):305-17. PubMed ID: 15947105 [Abstract] [Full Text] [Related]
39. Increased expression of matrix metalloproteinase-2: a diagnostic marker but not prognostic marker of papillary thyroid carcinoma. Korem S, Kraiem Z, Shiloni E, Yehezkel O, Sadeh O, Resnick MB. Isr Med Assoc J; 2002 Apr 07; 4(4):247-51. PubMed ID: 12001695 [Abstract] [Full Text] [Related]
40. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses]. Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP. Zhonghua Bing Li Xue Za Zhi; 2004 Jun 07; 33(3):212-6. PubMed ID: 15256110 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]